Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus-related chronic liver disease

World Journal of Gastroenterology

Volumn 11, Issue 25, 2005, Pages 3962-3965

  Meng, Xiang Wei ^a   Chi, Bao Rong ^a   Chen, Li Gang ^a   Zhang, Ling Ling ^a   Zhuang, Yan ^a   Huang, Hai Yan ^a   Sun, Xun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Chronic hepatitis C; HCV related liver cirrhosis; IFN receptor

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA1 INTERFERON; ALPHA1B INTERFERON; BETA INTERFERON RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CENTRAL VEIN; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CYTOPLASM; DRUG DOSE REGIMEN; DRUG RESPONSE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; LIVER CELL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NONHUMAN; PORTAL VEIN; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

EID: 22644444813     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i25.3962     Document Type: Article

References (15)

1. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T. Quantitiative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993; 104: 877-883
2. Kanai K, Kato M, Okamoto H. HCV genotypes in chronic hepatits C and response to interferon. Lancet 1992; 339: 1543
3. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K. Factors predictive of response to interferon -alpha therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-1094
4. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. Hepatology 1996; 24: 778-789
5. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional roles of type I and type II interferons in antiviral defense. Science 1994; 264: 1918-1921
6. Novick D, Cohen B, Rubinstein M. The human interferon-α/βreceptor Characterization and molecular cloning. Cell 1994; 77: 391-400
7. Colamonici OR, Domanski P. Identification of a novel subunit of the Type I interferon receptor localized to human chromosome. J Biol Chem 1993; 268: 10895-10899
8. Isimura. The significance of interferon in liver as an impact factor for hepatitis C therapy. Hepatology 1997; 38: 292-299
9. Fujiwara D, Hino K, Yamaguchi Y, Ren F, Satoh Y, Korenaga M, Okuda M, Okita K. Hepatic expression of type I interferon receptor for predicting response to interferon therapy in chronic hepatitis C patients: a comparison of immunohistochemical method vs competitive polymerase chain reaction assay. Hepatol Res 2003; 25: 377-384
10. Morita K, Tanaka K, Saito S, Kitamura T, Kondo M, Sakaguchi T, Morimoto M, Sekihara H. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection. Clin Gastroenterol 1998; 26: 135-140
11. Mizukoshi E, Kaneko S, Yanagi M, Ohno H, Kaji K, Terasaki S, Shimoda A, Matsushita E, Kobayashi K. Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients. J Med Virol 1998; 56: 217-223
12. Fujiwara D, Hino K, Yamaguchi Y, Kubo Y, Yamashita S, Uchida K, Konishi T, Nakamura H, Korenaga M, Okuda M, Okita K. Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study. J Viral Hepat 2004; 11: 136-140
13. Yamaguchi Y, Hino K, Fujiwara D, Ren F, Katoh Y, Satoh Y, Okita K. Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients. Dig Dis Sci 2002; 47: 1611-1617
14. Affabris E, Romeo G, Belardelli F, Jemma C, Mechti N, Gresser I, Rossi GB. 2-5A synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with alpha/beta interferon despite the presence of high-affinity interferon receptor sites. Virology 1983; 125: 508-512
15. Roffi L, Colloredo G, Antonelli G, Beliati G, Panizzuti F, Piperno A, Pozzi M, Ravizza D, Angeli G, Diaazani F, Mancia G. Breakthrough during recombinant interferon alpha therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management. Hepatology 1995; 21: 645-649